24 July 2017
ByAppeared in BioNews 910
Spanish fertility treatment provider IVI announced they have invested £15 million into the UK this year.
'This investment represents a strong commitment, not just to our patients in the UK, but to the burgeoning life sciences sector,' said Dr Enda McVeigh, CEO of IVI UK.
IVI is the world's largest assisted reproduction group. It was founded in 1990 and operates across 70 clinics worldwide, including three UK clinics in London, Tamworth and Chester which opened this year at an investment of £4 million. IVI says it provided over 37,000 treatments in 2016, and delivered over 160,000 births in the past 26 years.
The company said it is committed to leading the fertility sector in research and development, and has established a research partnership with the University of Oxford to pursue research into patient care and evidence-based treatments including IVF and ICSI.
'Through our research partnerships with Oxford University and leading fertility experts, our clinics significantly improve access to fertility treatment for people across the UK, offering only evidence-based treatments that are proven to increase the chances of successful conception,' said Dr McVeigh.
The UK is the world’s third largest global hub for innovation and development in the life sciences sector, according to a report published in May by the UK BioIndustry Association, with continued growth following the EU referendum.